Outcomes of Regional Consensus Treatment Guidelines for Management of Surgery, Invasive Procedures and Control of Hemorrhages in Patients with Bleeding Disorders; and Management of Thrombosis and Thromboprophylaxis in Patients with Thrombophilia


About this study

The purpose of this study is to develop consensus guidelines and establish baseline outcomes data for various clinical complications and procedural events requiring treatment in the population of patients.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • The subject population includes all patients with the underlying hemostatic disorder and clinical indication for one of the procedures/bleeding/thrombotic events for which guidelines have been developed and defined.
    • After the patient/guardian has had the study explained to them, had their questions answered and signed a written informed consent, they will be treated as defined by the guidelines and have demographic and outcomes data collected for analysis.

Exclusion Criteria:  

  • Patient must have a congenital bleeding or clotting disorder.  
  • No patients will be excluded based on gender, ethnicity or age.  


Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Rajiv Pruthi, M.B.B.S.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer